Top

13-06-2018 | Psoriatic arthritis | Article

Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life

Journal: Clinical Rheumatology

Authors: Sibel Zehra Aydin, Orhan Kucuksahin, Levent Kilic, Atalay Dogru, Ozun Bayindir, Cem Ozisler, Ahmet Omma, Emine Figen Tarhan, Abdulsamet Erden, Gezmis Kimyon, Meryem Can, Ediz Dalkilic, Sule Yavuz, Sibel Bakirci Ureyen, Esen Kasapoglu Gunal, Fatıma Arslan Alhussain, Lutfi Akyol, Ayse Balkarli, Sema Yilmaz, Muhammet Cinar, Muge Tufan Aydin, Dilek Solmaz, Ridvan Mercan, Sukran Erten, Umut Kalyoncu

Publisher: Springer London

Abstract

Psoriatic arthritis (PsA) may affect different joints, including the spine. The prevalence of spinal involvement is variable depending on the definition and a subset of patients have been identified in cohorts that do not have clinical features of axial disease and yet have imaging findings. Still, there is not a consensus on how and when to screen axial disease. In this study, we aimed to investigate factors associated with being underdiagnosed for axial psoriatic arthritis (axPsA) and its impacts on outcomes. Disease features and outcomes of axPsA according to the physician (n = 415) were compared with patients with imaging findings only (sacroiliitis fulfilling the modified New York criteria, n = 112), using data from a real-life PsA registry. Patients with imaging findings only were more frequently women (83/220 (37.7%) vs 29/122 (23.8%); p = 0.008). This group also had higher peripheral disease activity (imaging only vs clinical AxPsA: mean (SD) tender joint count 5.3 (6.1) vs 3.3 (4.7), swollen joint count 1.9 (2.9) vs 1.2 (2.4); p < 0.001 for both comparisons) and was less often treated using TNF inhibitors (16.1 vs 38.2%; p < 0.001) than patients who were classified as axPsA. Patient-reported outcomes were similar in both groups. PsA patients, especially women with more severe peripheral disease, have a higher risk of being underdiagnosed for axPsA. The severity of peripheral symptoms may be a risk factor to mask the spinal features of PsA.

Gladman DD (2015) Clinical features and diagnostic considerations in psoriatic arthritis. Rheum Dis Clin N Am 41:569–579. https://doi.org/10.1016/j.rdc.2015.07.003 CrossRef

Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55–78. https://doi.org/10.1016/0049-0172(73)90035-8 CrossRefPubMed

Hanly JG, Russell ML, Gladman DD (1988) Psoriatic spondyloarthropathy: a long term prospective study. Ann Rheum Dis 47:386–393. https://doi.org/10.1136/ard.47.5.386 CrossRefPubMedPubMedCentral

Battistone MJ, Manaster BJ, Reda DJ, Clegg DO (1999) The prevalence of sacroilitis in psoriatic arthritis: new perspectives from a large, multicenter cohort. A Department of Veterans Affairs Cooperative Study. Skeletal Radiol 28:196–201. https://doi.org/10.1007/s002560050500 CrossRefPubMed

Jadon DR, Sengupta R, Nightingale A, Lindsay M, Korendowych E, Robinson G, Jobling A, Shaddick G, Bi J, Winchester R, Giles JT, McHugh NJ (2017) Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis 76:701–707. https://doi.org/10.1136/annrheumdis-2016-209853 CrossRefPubMed

Queiro R, Belzunegui J, Gonzalez C et al (2002) Clinically asymptomatic axial disease in psoriatic spondyloarthropathy. A retrospective study. Clin Rheumatol 21:10–13. https://doi.org/10.1007/s100670200003 CrossRefPubMed

Gladman DD (1998) Psoriatic arthritis. Rheum Dis Clin N Am 24:829–844. https://doi.org/10.1016/S0889-857X(05)70044-2 CrossRef

Gladman DD (1994) Natural history of psoriatic arthritis. Baillie’res Clin Rheumatol 8:379–394. https://doi.org/10.1016/S0950-3579(94)80024-3 CrossRef

Gladman DD, Rahman P, Krueger GG, Mease PJ, Qureshi AA, Dutz JP, Lindqvist U, Carneiro S, Helliwell PS, Ujfalussy I, Gottlieb AB, Behrens F, Ståhle M (2008) Clinical and genetic registries in psoriatic disease. J Rheumatol 35:1458–1463PubMed

10.

Kalyoncu U, Bayindir O, Ferhat Oksuz M et al (2017) The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients. Rheumatology (Oxford) 56:279–286. https://doi.org/10.1093/rheumatology/kew375 CrossRef

11.

Van Der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368. https://doi.org/10.1002/art.1780270401 CrossRefPubMed

12.

Aydin SZ, Kasapoglu Gunal E, Kurum E, Akar S, Mungan HE, Alibaz-Oner F, Lambert RG, Atagunduz P, Marzo Ortega H, McGonagle D, Maksymowych WP (2017a) Limited reliability of radiographic assessment of spinal progression in ankylosing spondylitis. Rheumatology (Oxford) 56:2162–2169. https://doi.org/10.1093/rheumatology/kex321 CrossRef

13.

Aydin SZ, Kilic L, Kucuksahin O, Ureyen SB, Kalyoncu U (2017b) Performances of inflammatory back pain criteria in axial psoriatic arthritis. Rheumatology (Oxford) 56:2031–2032. https://doi.org/10.1093/rheumatology/kex307 CrossRef

14.

Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O’Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, Tuong W, Ritchlin CT (2016) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 68:1060–1071. https://doi.org/10.1002/art.39573 CrossRefPubMed

15.

Ramiro S, Smolen JS, Landewe R et al (2016) Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis 75:490–498. https://doi.org/10.1136/annrheumdis-2015-208466 CrossRefPubMed

Medicine Matters Rheumatology

Abstract